We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current NRC market cap is 241.85M. The company's latest EPS is USD 1.0801 and P/E is 9.75.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 38M | 35.31M | 35.02M | 35.82M | 36.91M |
| Operating Income | 11.71M | 8.76M | 8.87M | 7.98M | 9.59M |
| Net Income | 8.86M | 6.36M | 6.18M | 5.69M | 6.56M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 133.28M | 147.95M | 151.57M | 148.58M | 143.06M |
| Operating Income | 42.14M | 50.59M | 46.54M | 40.05M | 35.19M |
| Net Income | 37.26M | 37.47M | 31.8M | 30.97M | 24.78M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 122.44M | 120.91M | 119.1M | 131.8M | 132.54M |
| Total Liabilities | 73.48M | 83.97M | 78.9M | 97.18M | 101.26M |
| Total Equity | 48.96M | 36.95M | 40.2M | 34.62M | 31.28M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 133.42M | 157.54M | 130.46M | 122.44M | 132.54M |
| Total Liabilities | 69.11M | 72.2M | 58.43M | 73.48M | 101.26M |
| Total Equity | 64.32M | 85.34M | 72.03M | 48.96M | 31.28M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 38.11M | 12.04M | 18.82M | 28.25M | 34.63M |
| Investing | -15.78M | -4.14M | -9.41M | -15.84M | -20.28M |
| Financing | -40.71M | -12.85M | -15.58M | -15.6M | -16.76M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 40.64M | 46.34M | 36.27M | 38.11M | 34.63M |
| Investing | -3.72M | -8.51M | -9.84M | -15.78M | -20.28M |
| Financing | -15.5M | -18.16M | -55.58M | -40.71M | -16.76M |
| Market Cap | 241.85M |
| Price to Earnings Ratio | 9.75 |
| Price to Sales Ratio | 1.69 |
| Price to Cash Ratio | 57.07 |
| Price to Book Ratio | 7.72 |
| Dividend Yield | 4.55% |
| Shares Outstanding | 22.95M |
| Average Volume (1 week) | 88.73k |
| Average Volume (1 Month) | 91.32k |
| 52 Week Change | -69.39% |
| 52 Week High | 35.84 |
| 52 Week Low | 10.45 |
| Spread (Intraday) | 0.42 (3.9%) |
| Company Name | National Research Corporation |
| Address |
777 e wisconsin ave milwaukee, wisconsin 53202 5367 |
| Website | https://www.nrchealth.com |
| Industry | testing laboratories (8734) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
